Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Head and Neck Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    January 2024
  1. LI C, Guo H, Zhai P, Yan M, et al
    Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells.
    Cancer Res. 2024;84:258-275.
    PubMed     Abstract available


    December 2023
  2. SHI Q, Xu G, Jiang Y, Yang J, et al
    Phospholipase PLCE1 promotes transcription and phosphorylation of MCM7 to drive tumor progression in esophageal cancer.
    Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-1633.
    PubMed     Abstract available


    October 2023
  3. SMITH AE, Chan S, Wang Z, McCloskey A, et al
    Tipifarnib Potentiates the Antitumor Effects of PI3Kalpha Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
    Cancer Res. 2023;83:3252-3263.
    PubMed     Abstract available


  4. LEE RH, Johnson DE, Grandis JR
    To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
    Cancer Res. 2023;83:3162-3164.
    PubMed     Abstract available


    September 2023
  5. SFANOS KS
    Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
    Cancer Res. 2023;83:2985-2986.
    PubMed     Abstract available


  6. ARBORE G, Albarello L, Bucci G, Punta M, et al
    Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
    Cancer Res. 2023;83:2873-2888.
    PubMed     Abstract available


    August 2023
  7. WEED DT, Zilio S, McGee C, Marnissi B, et al
    The tumor immune microenvironment architecture correlates with risk of recurrence in head and neck squamous cell carcinoma.
    Cancer Res. 2023 Aug 21:CAN-23-0379. doi: 10.1158/0008-5472.CAN-23-0379.
    PubMed     Abstract available


    July 2023
  8. WU H, Leng X, Liu Q, Mao T, et al
    Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2023 Jul 11:CAN-22-2593. doi: 10.1158/0008-5472.CAN-22-2593.
    PubMed     Abstract available


    June 2023
  9. CHEN C, Shin JH, Fang Z, Brennan K, et al
    Targeting KDM2A Enhances T Cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2023 Jun 13:CAN-22-3114. doi: 10.1158/0008-5472.CAN-22-3114.
    PubMed     Abstract available


  10. SINGH PK, Mehla K
    LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis.
    Cancer Res. 2023;83:1759-1761.
    PubMed     Abstract available


  11. BOREDDY SR, Nair R, Pandey PK, Kuriakose A, et al
    BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFbeta Signaling to Durably Suppress Tumor Growth.
    Cancer Res. 2023;83:1883-1904.
    PubMed     Abstract available


    May 2023
  12. LI X, Wang C, Zhang H, Li Y, et al
    circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma.
    Cancer Res. 2023;83:1459-1475.
    PubMed     Abstract available


    February 2023
  13. JAGADEESHAN S, Prasad M, Badarni M, Ben Lulu T, et al
    Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer.
    Cancer Res. 2023 Feb 8:CAN-22-2586. doi: 10.1158/0008-5472.CAN-22-2586.
    PubMed     Abstract available


  14. ZHANG GC, Yu XN, Guo HY, Sun JL, et al
    PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.
    Cancer Res. 2023 Feb 1:OF1-OF17. doi: 10.1158/0008-5472.CAN-22-2156.
    PubMed     Abstract available


    January 2023
  15. GUAN L, Nambiar DK, Cao H, Viswanathan V, et al
    NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.
    Cancer Res. 2023 Jan 19:CAN-22-1903. doi: 10.1158/0008-5472.CAN-22-1903.
    PubMed     Abstract available


    December 2022
  16. SHAH PA, Sambandam V, Fernandez AM, Zhao H, et al
    Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2022;82:4444-4456.
    PubMed     Abstract available


    November 2022
  17. LIU Y, Kramer JR, Sandulache VC, Yu R, et al
    Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort.
    Cancer Res. 2022 Nov 15. pii: 710888. doi: 10.1158/0008-5472.CAN-22-1641.
    PubMed     Abstract available


    October 2022
  18. LIU J, Liu ZX, Li JJ, Zeng ZL, et al
    The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1alpha signaling in esophageal cancer.
    Cancer Res. 2022 Oct 20. pii: 709866. doi: 10.1158/0008-5472.CAN-22-1922.
    PubMed     Abstract available


    September 2022
  19. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
    Cancer Res. 2022;82:3187.
    PubMed    


  20. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
    Cancer Res. 2022;82:3188.
    PubMed    


    August 2022
  21. CHATURVEDI AK, Freedman ND, Abnet CC
    The Evolving Epidemiology of Oral Cavity and Oropharyngeal Cancers.
    Cancer Res. 2022;82:2821-2823.
    PubMed     Abstract available


    July 2022
  22. LIU T, Zhao X, Lin Y, Luo Q, et al
    Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression.
    Cancer Res. 2022;82:2520-2537.
    PubMed     Abstract available


  23. LIAO L, He Y, Li SJ, Zhang GG, et al
    Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
    Cancer Res. 2022;82:2444-2457.
    PubMed     Abstract available


    June 2022
  24. LI Y, Nie CJ, Hu L, Qin Y, et al
    Editor's Note: Characterization of a Novel Mechanism of Genomic Instability Involving the SEI1/SET/NM23H1 Pathway in Esophageal Cancers.
    Cancer Res. 2022;82:2197.
    PubMed    


    April 2022
  25. LIN C, Song L, Gong H, Liu A, et al
    Editor's Note: Nkx2-8 Downregulation Promotes Angiogenesis and Activates NF-kappaB in Esophageal Cancer.
    Cancer Res. 2022;82:1670.
    PubMed    


  26. LEE KK, Rishishwar L, Ban D, Nagar SD, et al
    Association of Genetic Ancestry and Molecular Signatures with Cancer Survival Disparities: A Pan-Cancer Analysis.
    Cancer Res. 2022;82:1222-1233.
    PubMed     Abstract available


    March 2022
  27. DUAN X, Chen H, Zhou X, Liu P, et al
    EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Cancer Res. 2022;82:1070-1083.
    PubMed     Abstract available


  28. MOLKENTINE DP, Molkentine JM, Bridges KA, Valdecanas DR, et al
    p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.
    Cancer Res. 2022;82:916-928.
    PubMed     Abstract available


  29. YOU B, Xia T, Gu M, Zhang Z, et al
    AMPK-mTOR-Mediated Activation of Autophagy Promotes Formation of Dormant Polyploid Giant Cancer Cells.
    Cancer Res. 2022;82:846-858.
    PubMed     Abstract available


    October 2021
  30. LIN A, Ji P, Niu X, Zhao X, et al
    CstF64-induced shortening of the BID 3'UTR promotes esophageal squamous cell carcinoma progression by disrupting ceRNA crosstalk with ZFP36L2.
    Cancer Res. 2021 Oct 4. pii: 0008-5472.CAN-21-1201.
    PubMed     Abstract available


    September 2021
  31. STOSIC A, Fuligni F, Anderson ND, Davidson S, et al
    Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma.
    Cancer Res. 2021 Sep 17. pii: 0008-5472.CAN-21-0761.
    PubMed     Abstract available


  32. KIM J, Park B, Ha J, Steinberg I, et al
    Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo.
    Cancer Res. 2021;81:4849-4860.
    PubMed     Abstract available


    August 2021
  33. HIRATA H, Niida A, Kakiuchi N, Uchi R, et al
    The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy.
    Cancer Res. 2021 Aug 19. pii: 0008-5472.CAN-21-0653.
    PubMed     Abstract available


    July 2021
  34. GE J, Wang J, Xiong F, Jiang X, et al
    Epstein-Barr virus-encoded circular RNA circBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1.
    Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-20-4321.
    PubMed     Abstract available


  35. MADABHUSHI A, Toro P, Willis JE
    Artificial Intelligence in Surveillance of Barrett's Esophagus.
    Cancer Res. 2021;81:3446-3448.
    PubMed     Abstract available


    June 2021
  36. CHEN Z, Zhang C, Chen J, Wang D, et al
    The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
    Cancer Res. 2021 Jun 24. pii: 0008-5472.CAN-20-3659.
    PubMed     Abstract available


  37. WATERHOUSE DJ, Januszewicz W, Ali S, Fitzgerald RC, et al
    Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus.
    Cancer Res. 2021;81:3415-3425.
    PubMed     Abstract available


  38. LIU SC, Tsang NM, Lee PJ, Sui YH, et al
    Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment.
    Cancer Res. 2021;81:3283-3294.
    PubMed     Abstract available


    May 2021
  39. LI Y, Wang M, Yang M, Xiao Y, et al
    Nicotine-induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-4160.
    PubMed     Abstract available


    April 2021
  40. SAULTERS E, Woolley JF, Varadarajan S, Jones TM, et al
    STINGing viral tumours: What we know from head and neck cancers.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0785.
    PubMed     Abstract available


  41. ALVAREZ-TROTTA A, Guerrant W, Astudillo L, Lahiry M, et al
    Pharmacological disruption of the Notch1 transcriptional complex inhibits tumor growth by selectively targeting cancer stem cells.
    Cancer Res. 2021 Apr 5. pii: 0008-5472.CAN-20-3611.
    PubMed     Abstract available


    March 2021
  42. MA S, Zhou B, Yang Q, Pan Y, et al
    A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.
    Cancer Res. 2021;81:1216-1229.
    PubMed     Abstract available


    February 2021
  43. HUMTSOE JO, Kim HS, Leonard B, Ling S, et al
    Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
    Cancer Res. 2021;81:1001-1013.
    PubMed     Abstract available


  44. CURTIUS K, Dewanji A, Hazelton WD, Rubenstein JH, et al
    Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling.
    Cancer Res. 2021;81:1123-1134.
    PubMed     Abstract available


    January 2021
  45. LIU J, Jiang X, Zou A, Mai Z, et al
    circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
    Cancer Res. 2021;81:344-355.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.